SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (14543)2/10/1998 8:56:00 PM
From: Torben Noerup Nielsen  Read Replies (6) of 32384
 
Tony,

>> But what is the deal with the hyperlipidemia?
>> Is this also a problem with targretin?

> Somehow I feel that "this will be viwed as positive news" for
> Ligand.

I get the distinct feeling that you are being sarcastic in the above. While I agree that Henry is likely to put the best possible spin on it (no offense intended Henry :-)), I think that the announcement is very good news indeed for LGND.

Please note that the capsules are intended for treatment of the advanced forms of KS. That is, the disease has attacked internal organs so that you cannot treat it with a gel any longer. These people are going to die if nothing is done. The capsules may allow them to live a little longer or they may allow them to be more comfortable during whatever time they have left.

Also, a drug with this kind of response rate against KS seems likely to have a response against other serious diseases. At least I would guess so.

Oh well, we will see how the market reacts. This may not do a lot for the stock, but I suspect that an NDA will once it is submitted. And just wait to see what happens when LGND gets their first NDA approved. At this point, it is hard to see how the gel could be rejected.

Cheers, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News